StonvexLoading…
StonvexStonvexStonvexCore line items from DEO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-06-30 | Annual 2024 2024-06-30 | Annual 2023 2023-06-30 | Annual 2022 2022-06-30 |
|---|---|---|---|---|
Revenue | $27.96B | $27.89B | $28.27B | $29.75B |
Operating Income | $4.33B | $6.00B | $5.55B | $5.90B |
Net Income | $2.54B | $4.17B | $4.48B | $4.41B |
EPS (Diluted) | $1.06 | $1.73 | $1.96 | $1.84 |
Total Assets | $49.32B | $45.47B | $44.88B | $44.18B |
Total Liabilities | $36.14B | $33.40B | $33.17B | $32.67B |
Cash & Equivalents | $2.20B | $1.13B | $1.81B | $2.77B |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | Not available | Not available | Not available | Not available |